01—Abstract
Summary
Summary of the 10-Q filed October 18, 2024. Cited figures are marked; the original filing is the authoritative source.
Intuitive Surgical Inc. (ISRG) reported strong third-quarter results for the period ending September 29, 2024, demonstrating robust top-line growth and improving profitability.
Total revenue surged 17% year-over-year to $2.04 billiona, fueled by significant increases in both instruments and accessories revenue (+18%) and systems revenue (+17%). This growth was primarily driven by a 17% increase in total da Vinci procedures and the successful launch and placement of 110 new da Vinci 5 systems during the quarter. The company also reported a substantial increase in operating income, up 24% to $577 million, reflecting improved gross margins to 67.4% and effective management of operating expenses.
This strong financial performance, coupled with a growing installed base of da Vinci and Ion systems, positions Intuitive Surgical favorably. The company maintains a healthy balance sheet with $8.31 billionb in cash, cash equivalents, and investments, providing ample resources for continued investment in innovation and global expansion.
02—Key points
Key Highlights
- Total revenue increased 17% year-over-year to $2.04 billion, driven by strong performance in instruments and accessories, systems, and service revenue.
- Da Vinci procedures grew 18% year-over-year, demonstrating continued adoption and utilization of the company's robotic surgical systems.
- Systems revenue saw a 17% increase, supported by a 17% rise in da Vinci system placements (379 systems placed in Q3 2024) and the introduction of the da Vinci 5 system.
- Operating income grew significantly by 24% to $577 million, reflecting improved gross profit margins and disciplined expense management.
- The installed base of da Vinci systems expanded by 15% to approximately 9,539 systems, indicating sustained market penetration.
- Ion system procedures saw substantial growth of 73%, reflecting increasing adoption of the endoluminal system.
- The company ended the quarter with a strong liquidity position, holding $8.31 billion in cash, cash equivalents, and investments.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q3 FY2024, Intuitive Surgical kept $0.28.
- Revenue$2.04B100.0%
- Cost of revenue−$664.2M32.6%
- Gross profit$1.37B67.4%
- Operating costs−$796.6M39.1%
- Operating income$577.3M28.3%
- Interest, other & tax−$12.2M0.6%
- Net income$565.1M27.7%
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2024filed October 18, 2024Financial Statements
Q3 FY2024 against Q3 FY2023
| Line item | Q3 FY2024Q3 FY2023 | Change |
|---|---|---|
| Revenue | $2.04B$1.74B | +16.9% |
| Cost of Revenue | $664.20M$576.50M | +15.2% |
| Gross Profit | $1.37B$1.17B | +17.7% |
| R&D Expenses | $286.00M$249.40M | +14.7% |
| SG&A Expenses | $510.60M$452.00M | +13.0% |
| Operating Expenses | $796.60M$701.40M | +13.6% |
| Operating Income | $577.30M$465.80M | +23.9% |
| Net Income | $565.10M$415.70M | +35.9% |
| EPS (Basic) | $1.59$1.18 | +34.7% |
| EPS (Diluted) | $1.56$1.16 | +34.5% |
| Shares Outstanding (Basic) | 355.80M351.70M | +1.2% |
| Shares Outstanding (Diluted) | 362.70M358.20M | +1.3% |
05—Questions
Frequently Asked Questions
What are the key drivers of Intuitive Surgical's revenue growth in this quarter?
Revenue growth was primarily driven by a 17% increase in total da Vinci procedures performed, a 17% rise in systems revenue due to increased system placements (including the new da Vinci 5 system), and an 18% increase in instruments and accessories revenue, which is closely tied to procedure volume. Service revenue also contributed positively with an 12% increase.
How is the launch of the new da Vinci 5 system performing?
The company placed 110 da Vinci 5 systems in the third quarter of 2024, contributing to the overall 17% increase in systems revenue. This new generation system, featuring advanced capabilities like force feedback, is part of the company's strategy to drive future growth and upgrade cycles.
What is the outlook for procedure volumes, and how are they impacted by external factors?
Procedure volumes continue to show strong growth (18% for da Vinci procedures in Q3). While the company highlights factors like hospital staffing shortages and financial pressures which may lead to cautious capital spending, the overall procedure growth indicates resilience and continued adoption of minimally invasive care. The Ion system also demonstrated significant growth in procedures (73%).
What is the company's financial health and liquidity situation?
Intuitive Surgical maintains a strong financial position with $8.31 billion in cash, cash equivalents, and investments as of September 30, 2024. This robust liquidity provides ample resources to fund operations, invest in research and development, and pursue growth opportunities.
06—Continue